Tag: Louis Artime
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
South Korea’s maritime hub status grows with advanced ports, shipbuilding strength, trade volumes and dispute resolution.
Follow us on LinkedIn